India News | Union Health Minister Reviews Availability of COVID-19 Essential Drugs, Their Buffer Stocks
Get latest articles and stories on India at LatestLY. Union Health Minister Mansukh Mandaviya on Wednesday reviewed the supply and availability of COVID-19 related essential medicines in the country.
New Delhi [India], September 1 (ANI): Union Health Minister Mansukh Mandaviya on Wednesday reviewed the supply and availability of COVID-19 related essential medicines in the country.
During the review, it was noted that sufficient stocks of all the essential medicines are available. Raw materials for these drugs are also available in enough quantities, according to the Ministry of Health and Family Welfare
Also Read | Punjab: Minor Girl Allegedly Raped in Amritsar; Case Registered Under POCSO Act.
The strategic buffer stock has been created for 8 drugs, all of these are available in the country.
Eight drugs include Tocilizumab, Methyl Prednisolone, Enaxopirin, Dexamethasone, Remdesivir, Amphotericin B Deoxycholate, Posaconazole and Intravenous Immunoglobulin (IVIG)
Also Read | African Swine Fever Kills 25,260 Pigs in Mizoram Since March 2021; Rs 121 Crore Loss Reported in State.
Senior Officials of the Ministry of Health and Family Welfare were present in the review meeting. (ANI)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)